Aberrant CRM1-dependent, NES-mediated nucleocytoplasmic transport and cytoplasmic accumulation of AML-associated mutant forms of NPM (collectively termed NPMc+), has been attributed a driver role in the development of this malignancy [29, 30]. Here, NPM1 is linked to acute myeloid leukemia.